West Paces Advisors’s AtriCure ATRC Stock Holding History

West Paces Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$700	Buy	+25	New	+$703	﹤0.01%	684
2025 Q2	–	Sell	-25	Closed	-$807	–	227
2025 Q1	$807	Hold	25	–	–	﹤0.01%	507
2024 Q4	$764	Hold	25	–	–	﹤0.01%	505
2024 Q3	$701	Hold	25	–	–	﹤0.01%	499
2024 Q2	$569	Hold	25	–	–	﹤0.01%	525
2024 Q1	$761	Hold	25	–	–	﹤0.01%	529
2023 Q4	$892	Hold	25	–	–	﹤0.01%	516
2023 Q3	$1.09K	Hold	25	–	–	﹤0.01%	460
2023 Q2	$1.23K	Hold	25	–	–	﹤0.01%	483
2023 Q1	$1.04K	Hold	25	–	–	﹤0.01%	507
2022 Q4	$1.11K	Hold	25	–	–	﹤0.01%	468
2022 Q3	$978	Hold	25	–	–	﹤0.01%	469
2022 Q2	$1.02K	Hold	25	–	–	﹤0.01%	520
2022 Q1	$1.64K	Hold	25	–	–	﹤0.01%	495
2021 Q4	$1.74K	Hold	25	–	–	﹤0.01%	528
2021 Q3	$1.74K	Hold	25	–	–	﹤0.01%	525
2021 Q2	$1.98K	Hold	25	–	–	﹤0.01%	541
2021 Q1	$1.64K	Hold	25	–	–	﹤0.01%	417
2020 Q4	$1.39K	Hold	25	–	–	﹤0.01%	401
2020 Q3	$998	Buy	+25	New	+$1.06K	﹤0.01%	402

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

West Paces Advisors's ATRC Position: Q2 2026 in Review

West Paces Advisors opened a new position in AtriCure (ATRC) in Q2 2026: 25 shares worth $700. The stake represents ﹤0.01% of the portfolio and ranks #684 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in ATRC as recently as Q1 2025.

West Paces Advisors first reported a position in ATRC in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.98K in Q2 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

West Paces Advisors held 25 shares of AtriCure worth $700 as of Q2 2026.
AtriCure was a new West Paces Advisors position in Q2 2026.
AtriCure made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #684 holding.
West Paces Advisors first reported a position in AtriCure in Q3 2020 and has held it in 20 quarters since.
West Paces Advisors's AtriCure position peaked at $1.98K in Q2 2021.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.